GeneDx Holdings Corp vs TeraWulf Inc — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while TeraWulf Inc trades at $20.11 (market cap $9.35B). The key difference: TeraWulf Inc is far larger — about 5.2× GeneDx Holdings Corp's market cap, and TeraWulf Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| WGS | WULF | |
|---|---|---|
Market Cap | $1.80B | $9.35B |
Sector | Technology | Technology |
52-Week High | $167.51 | $28.98 |
52-Week Low | $34.51 | $4.76 |
Enterprise Value | $1.80B | $12.03B |
Trailing returns across standard periods
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →